State Street Corp Renovo Rx, Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Renovo Rx, Inc. stock. As of the latest transaction made, State Street Corp holds 26,152 shares of RNXT stock, worth $24,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,152
Previous 26,152
-0.0%
Holding current value
$24,844
Previous $27,000
37.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNXT
# of Institutions
21Shares Held
2MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$926,2500.27% of portfolio
-
Geode Capital Management, LLC Boston, MA236KShares$223,9600.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX197KShares$187,3870.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$134,4120.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$92,3060.01% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $8.61M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...